直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Press Release

Finnegan Releases eBook on Patent Activities in the U.S. Chemical and Pharmaceutical Industries

December 2, 2013

FOR IMMEDIATE RELEASE

December 2, 2013

Contact:    Adriana L. Burgy, Partner and eBook Editor
                    Email

Finnegan Releases eBook on Patent Activities in the U.S. Chemical and Pharmaceutical Industries

WASHINGTON, DC — Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, one of the world’s largest intellectual property law firms, is pleased to release The Chemical and Pharmaceutical Innovation Report 2013. The Report 2013 is a complimentary eBook for patent practitioners, entrepreneurs, business executives, venture capitalists, and inventors that benchmarks the patent activities of the U.S. chemical and pharmaceutical industries from 2006 to 2012.

“Whether your company is emerging or well established, intellectual property—particularly patents—plays an important role in its value,” stated Adriana L. Burgy, Finnegan partner and eBook editor. “Today’s patents are not just for corporate display cases—they are strategic instruments crucial for business innovation and growth. In the competitive chemical and pharmaceutical industries, patents protect products that have years of research and development invested in them.”

The Report 2013 examines the chemical and pharmaceutical industries’ patent activities by reviewing:

  1. Patenting and Application Publication Trends
  2. District Court Litigation Trends
  3. Appellate Litigation Trends
  4. The America Invents Act
  5. Chemical and Pharmaceutical Federal Circuit Cases from 2006 to 2012

Complimentary copies of The Report 2013 eBook are available on Finnegan’s website.

About Finnegan

With more than 350 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in Washington, DC; Atlanta, Georgia; Boston, Massachusetts; Palo Alto, California; Reston, Virginia; London; Shanghai; Taipei; and Tokyo, the firm practices all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com. Follow us on LinkedIn or on Twitter.

###

Related Professionals

Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email

Related News

Award/Ranking

Finnegan Wins “Hatch-Waxman Litigation Firm of the Year – Branded” and David Weingarten Wins “Patent Strategy Attorney of the Year (South)” at the LMG Life Sciences Americas Awards

September 11, 2026

Commentary

Bloomberg Law Q&A with Finnegan IP Lawyer Christian Hurt

September 11, 2026

Media Mention

Finnegan Opens First Texas Office with ‘Two Leaders with Genuine Local Roots'

September 7, 2026

Commentary

Finnegan Joins Growing Wave of Firms Moving into Texas

September 4, 2026

Press Release

Finnegan Expands U.S. Platform with Launch of Dallas Office

September 2, 2026

Commentary

Finnegan Enters Texas Market with Former USPTO Atty

September 2, 2026

Commentary

IP Firm Finnegan Moves into Texas with Dallas Office

September 2, 2026

Media Mention

Finnegan Named a Finalist in Three Categories in Law.com’s  D.C. Legal Awards 

August 24, 2026

Commentary

East Texas Reclaims Its Patent Crown

August 21, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP